In this session, Chelsea Christensen will discuss how the use of ZOLL’s Heart Failure Management System* (HFMS) has assisted in reducing 30-day HF readmission rates to single digits. Research published in JACC Heart Failure shows that the use of HFMS reduces 90-day HF readmissions by 38%.¹

Session information:

Date: Sunday, March 29
Time: 9:30-10:00 AM CDT
Location: Innovation Stage, Expo Hall #2064

This event is not part of ACC.26, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Register to Attend

^*FDA registered name: μCor™ Heart Failure and Arrhythmia Management System

Boehmer, J, Cremer, S, Abo-Auda, W. et al. Impact of a Novel Wearable Sensor on Heart Failure Rehospitalization: An Open-Label Concurrent-Control Clinical Trial. J Am Coll Cardiol HF. 2024 Dec, 12 (12) 2011–2022. https://doi.org/10.1016/j.jchf.2024.07.022